BEGIN:VCALENDAR VERSION:2.0 PRODID:-//ChamberMaster//Event Calendar 2.0//EN METHOD:PUBLISH X-PUBLISHED-TTL:P1H REFRESH-INTERVAL:P1H CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:America/Chicago BEGIN:DAYLIGHT RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU DTSTART:20070101T000000 TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:Central Daylight Time END:DAYLIGHT BEGIN:STANDARD RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU DTSTART:20070101T000000 TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:Central Standard Time END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/Chicago:20220916T190000 DTEND;TZID=America/Chicago:20220916T200000 X-MICROSOFT-CDO-ALLDAYEVENT:FALSE SUMMARY:VIRTUAL: "Secondary IOLs for children: Who\, When\, and How" featuring Deborah K. VanderVeen\, MD DESCRIPTION:Deborah K. VanderVeen\, MD\nAssociate\, Department of Ophthalmology\; Director\, Pediatric Cataract Service\nAssociate Professor\, Harvard Medical SchoolEducationUndergraduate School\nKansas State University\n1985\, Manhattan\, KSMedical School\nUniversity of Kansas Medical Center\n1993\, Kansas City\, KSInternship\nUniversity of Kansas Medical Center\n1994\, Kansas City\, KSResidency\nBoston University Medical School\n1997\, Boston\, MAFellowship\nBoston Children's Hospital\n1998\, Boston\, MA\nEducational Objectives:\nFollowing this presentation\, the participant should be able to:Identify characteristics of patients (eyes) that are good candidates for IOL implantationList 3 factors to consider for timing of IOL implantationRecognize factors that help determine which implantation technique may be best suited for a childACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Minnesota Medical Association and University of Minnesota\, Department of Ophthalmology. The Minnesota Medical Association (MMA) is accredited by the ACCME to provide continuing medical education for physicians. CME STATEMENT The Minnesota Medical Association designates this Regularly Scheduled Series for a maximum of 1.0 AMA PRA Category 1 Credit(s) . Physicians should claim only the credit commensurate with the extent of their participation in the activity.This meeting is being co-sponsored by the University of Minnesota. X-ALT-DESC;FMTTYPE=text/html:
Deborah K. VanderVeen\, MD
Associate\, Department of Ophthalmology\; Director\, Pediatric Cataract Service
Associate Professor\, Harvard Medical School
Education
Undergraduate School
Kansas State University
1985\, Manhattan\, KS
Medical School
University of Kansas Medical Center
1993\, Kansas City\, KS
Internship
University of Kansas Medical Center
1994\, Kansas City\, KS
Residency
Boston University Medical School
1997\, Boston\, MA
Fellowship
Boston Children'\;s Hospital
1998\, Boston\, MA
Educational Objectives:
Following this presentation\, the participant should be able to:
ACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Minnesota Medical Association and University of Minnesota\, Department of Ophthalmology. The Minnesota Medical Association (MMA) is accredited by the ACCME to provide continuing medical education for physicians.  \;  \;
CME STATEMENT The Minnesota Medical Association designates this Regularly Scheduled Series for a maximum of 1.0 AMA PRA Category 1 Credit(s)&trade\; . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This meeting is being co-sponsored by the University of Minnesota.